Stock Events

Stock Events

Sonnet Biotherapeutics (SONN) Q2 2023 Earnings

14AugConfirmed

Dec 22

Q4 2022

Q1 2023

Q2 2023

-1.67

-1.16

-0.64

-0.13

Details

Expected EPS

-0.31

Actual EPS

-0.13

Surprise EPS

0.18

Surprise Percent

+58.06%

Description

Sonnet Biotherapeutics (SONN) has reported earnings of -0.13 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.